FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Zydus Pharmaceuticals Carvedilol Tablets Recall

Carvedilol Tablets, USP, 3

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class III
Reported by FDA
May 1, 2019
Recall ID
D-1242-2019
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled Carvedilol Tablets starting Apr 22, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1242-2019 on May 1, 2019. Reason: Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

Product description

Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05

Lot numbers, UPCs & expiration codes

Lot #: Z803518, Exp 08/2020

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1242-2019
Classification
Class III
Status
Terminated
Recall initiated
Apr 22, 2019
FDA report date
May 1, 2019
Quantity
7668 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-1242-2019, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
82682
Address
73 Route 31 N
Code information
Lot #: Z803518, Exp 08/2020
Postal code
08534-3601
Report date
May 1, 2019
Product type
Drugs
Recall number
D-1242-2019
Classification
Class III
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
7668 bottles
Termination date
Jan 14, 2021
Reason for recall
Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 22, 2019
Initial firm notification
Letter
Center classification date
Apr 25, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1242-2019, published May 1, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls